Brining Expertise in NK Cell Therapy to Advance Efforts in Cancer Prevention, early detection, and treatment development ▶ New focus on NK cell therapy for.
South Korea-based GC Cell and India-based Rivaara have inked a licensing agreement to commercialize the autologous treatment in India, Sri Lanka, and Bangladesh.